Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Prognostic molecular markers in pediatric liver disease - Are there any?

Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. TNF-α-induced down-regulation of CDX2 suppresses MEP1A expression in colitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Cell-free DNA in newly diagnosed patients with glioblastoma - a clinical prospective feasibility study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Torque-Teno virus viral load as a potential endogenous marker of immune function in solid organ transplantation

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Number of hospital contacts with alcohol problems predicts later risk of alcoholic liver cirrhosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Pediatric liver disease (PLD) is a major cause of severe morbidity and prolonged hospitalizations in children. Stratifying patients in terms of prognosis remains challenging. The limited knowledge about molecular mechanisms causing and accompanying PLD remains the main obstacle in a search for reliable prognostic biomarkers. A systematic search of MEDLINE via PubMed and Embase via OVID was conducted on studies published between August 2007 and August 2017. Molecular markers with a prognostic potential in terms of survival, need for liver transplantation or disease progression/regression were selected. In general, identified studies were single center smaller case-control studies or case series with a low level of evidence and a high risk of bias. Only 23 studies comprising 898 patients could be included, mostly focusing on biliary atresia, non-alcoholic fatty liver disease, viral hepatitis, and LT; and markers related to morphogenesis and fibrosis. Furthermore, molecular markers in metabolic pathways and inflammation shown to be relevant, however requiring further validation. Hence, further biological and clinical studies are needed to gain greater molecular insight into PLD.

OriginalsprogEngelsk
TidsskriftBiochimica et Biophysica Acta - Molecular Basis of Disease
Vol/bind1865
Udgave nummer3
Sider (fra-til)577-586
Antal sider10
ISSN0925-4439
DOI
StatusUdgivet - 1 mar. 2019

ID: 56502503